Host responses to mucosal biofilms in the lung and gut
- PMID: 32112046
- PMCID: PMC8323778
- DOI: 10.1038/s41385-020-0270-1
Host responses to mucosal biofilms in the lung and gut
Abstract
The impact of the human microbiome on health and disease is of utmost importance and has been studied intensively in recent years. Microbes promote immune system development and are essential to the production and absorption of nutrients for the host but are also implicated in disease pathogenesis. Particularly, bacterial biofilms have long been recognized as contributors to chronic infections and diseases in humans. However, our understanding of how the host responds to the presence of biofilms, specifically the immune response to biofilms, and how this contributes to disease pathogenesis is limited. This review aims to highlight what is known about biofilm formation and in vivo models available for the biofilm study. We critique the contribution of biofilms to human diseases, focusing on the lung diseases, cystic fibrosis and chronic obstructive pulmonary disease, and the gut diseases, inflammatory bowel disease and colorectal cancer.
Conflict of interest statement
Conflict of interest: CLS reports research support from Bristol Myers Squibb, Merck, and Janssen Pharmaceuticals, Inc. FH participated in a grant review for Sanofi.
Figures
References
-
- Young VB The role of the microbiome in human health and disease: An introduction for clinicians. BMJ 356, j831 (2017). - PubMed
-
- Hall-Stoodley L, Costerton JW & Stoodley P Bacterial biofilms: From the natural environment to infectious diseases. Nat. Rev. Microbiol 2, 95–108 (2004). - PubMed
-
- Dang AT & Marsland BJ Microbes, metabolites, and the gut–lung axis. Mucosal Immunol. 12, 843–850 (2019). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
